Insider Buying: Cosmos Health Inc. (NASDAQ:COSM) CEO Purchases 51,414 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 51,414 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was acquired at an average cost of $0.66 per share, with a total value of $33,933.24. Following the completion of the acquisition, the chief executive officer now directly owns 4,255,103 shares in the company, valued at approximately $2,808,367.98. This represents a 1.22 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, January 22nd, Grigorios Siokas purchased 38,900 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.77 per share, with a total value of $29,953.00.
• On Friday, January 17th, Grigorios Siokas purchased 29,158 shares of Cosmos Health stock. The shares were bought at an average price of $0.86 per share, for a total transaction of $25,075.88.
• On Wednesday, January 15th, Grigorios Siokas bought 62,500 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.80 per share, for a total transaction of $50,000.00.
• On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.61 per share, with a total value of $99,836.26.
• On Friday, December 20th, Grigorios Siokas acquired 257,334 shares of Cosmos Health stock. The stock was purchased at an average price of $0.58 per share, with a total value of $149,253.72.

Cosmos Health Price Performance

Cosmos Health stock traded up $0.01 during midday trading on Friday, hitting $0.67. The company’s stock had a trading volume of 21,668 shares, compared to its average volume of 765,073. Cosmos Health Inc. has a 12 month low of $0.47 and a 12 month high of $1.58. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $15.68 million, a PE ratio of -0.28 and a beta of 5.57. The stock’s 50-day moving average price is $0.73 and its 200-day moving average price is $0.89.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.